DAT Assay(s)

Background Information

The dopamine transporter (DAT), encoded by the SLC6A3 gene, is a sodium- and chloride-dependent symporter responsible for the reuptake of dopamine from the synaptic cleft into presynaptic neurons. By tightly regulating extracellular dopamine levels, DAT plays a critical role in modulating dopaminergic signaling in the central nervous system, particularly within regions such as the striatum, nucleus accumbens, and prefrontal cortex. Dysregulation of DAT function has been implicated in a variety of neurological and psychiatric disorders, including Parkinson’s disease, attention-deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders.

Family: SLC Transporter
Protein Name: DAT
Gene Name: SLC6A3

Organism : Human
Therapeutic Area: CNS

Assay Information

Validated Assay(s): Neurotransmitter Uptake Assay
Assay type: Cell-based
Method: Fluorescence

Instrumentation: FLIPR, Panoptic, Flexstation
Plate Format: 96- or 384-well
Expression: Stable
Cell type: HEK293T

Testing Information

Functional Mode(s): Inhibitor
Reference compound(s): Dopamine

Dose response curve for a DAT inhibition assay using a Neurotransmitter Uptake assay and the inhibitor, GBR-12909.

Enquire now